Skip to main content

Brevan Howard Capital Management LP

Position in BBIO — BridgeBio Pharma, Inc.

CIK 1512857 ST. HELIER, Y9

Position in BBIO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$11,598,546
+$5,541,158 QoQ
Shares Held
155,727
+90.9% QoQ
Ownership
0.080%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#112
of 469 holders
Holding Since
Jun 2024
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BBIO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Brevan Howard Capital Management LP holds $183,834,510 across 129 Biotechnology names. BBIO ranks #3 (6.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 BBIO
BridgeBio Pharma, Inc.
This page
155,727 $11,598,546

All Filings in BBIO

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11,598,546 155,727
2026-03-31 $6,057,388 81,570
2025-12-31 $13,272,773 173,523
2025-09-30 $2,722,590 52,418
2025-06-30 $4,495,469 104,110
2024-12-31 $405,014 14,760
2024-09-30 $623,311 24,482
2024-06-30 $333,976 13,185